Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Gabrielson

Showing results (91-100 of 134) with videos related to

Pageof 14
Sort By:
Cancer Research|October 3, 2008
RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapyAnju Singh, Swetlana Boldin-Adamsky, Rajesh K Thimmulappa, et al.
Molecular Cancer Research : MCR|March 26, 2003
Molecular markers in ductal carcinoma in situ of the breastDale Porter, Jaana Lahti-Domenici, Aparna Keshaviah, et al.
Cell Death & Disease|February 5, 2022
Cathepsin D as a potential therapeutic target to enhance anticancer drug-induced apoptosis via RNF183-mediated destabilization of Bcl-xL in cancer cellsSeung Un Seo, Seon Min Woo, Seung-Soon Im, et al.
Journal of Hematology & Oncology|December 8, 2020
Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targetsYangying Zhou, T Mamie Lih, Jianbo Pan, et al.
Cancer Genomics & Proteomics|November 26, 2014
Metabolic profile of triple-negative breast cancer in African-American women reveals potential biomarkers of aggressive diseaseYasmine M Kanaan, Brante P Sampey, Desta Beyene, et al.
Annals of Surgical Oncology|July 24, 2015
Intraoperative Assessment of Final Margins with a Handheld Optical Imaging Probe During Breast-Conserving Surgery May Reduce the Reoperation Rate: Results of a Multicenter StudyAdam M Zysk, Kai Chen, Edward Gabrielson, et al.
NPJ Breast Cancer|February 7, 2020
DNA methylation markers predict recurrence-free interval in triple-negative breast cancerMary Jo Fackler, Soonweng Cho, Leslie Cope, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2009
African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white womenAni Balmanoukian, Zhe Zhang, Stacie Jeter, et al.
Ebiomedicine|June 23, 2016
Epstein-Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant TransformationHai Hu, Man-Li Luo, Christine Desmedt, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 26, 2003
WNT7a induces E-cadherin in lung cancer cellsTatsuo Ohira, Robert M Gemmill, Kevin Ferguson, et al.
Pageof 14

Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Cancer Research|October 3, 2008
RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapyAnju Singh, Swetlana Boldin-Adamsky, Rajesh K Thimmulappa, et al.
Molecular Cancer Research : MCR|March 26, 2003
Molecular markers in ductal carcinoma in situ of the breastDale Porter, Jaana Lahti-Domenici, Aparna Keshaviah, et al.
Cell Death & Disease|February 5, 2022
Cathepsin D as a potential therapeutic target to enhance anticancer drug-induced apoptosis via RNF183-mediated destabilization of Bcl-xL in cancer cellsSeung Un Seo, Seon Min Woo, Seung-Soon Im, et al.
Journal of Hematology & Oncology|December 8, 2020
Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targetsYangying Zhou, T Mamie Lih, Jianbo Pan, et al.
Cancer Genomics & Proteomics|November 26, 2014
Metabolic profile of triple-negative breast cancer in African-American women reveals potential biomarkers of aggressive diseaseYasmine M Kanaan, Brante P Sampey, Desta Beyene, et al.
Annals of Surgical Oncology|July 24, 2015
Intraoperative Assessment of Final Margins with a Handheld Optical Imaging Probe During Breast-Conserving Surgery May Reduce the Reoperation Rate: Results of a Multicenter StudyAdam M Zysk, Kai Chen, Edward Gabrielson, et al.
NPJ Breast Cancer|February 7, 2020
DNA methylation markers predict recurrence-free interval in triple-negative breast cancerMary Jo Fackler, Soonweng Cho, Leslie Cope, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2009
African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white womenAni Balmanoukian, Zhe Zhang, Stacie Jeter, et al.
Ebiomedicine|June 23, 2016
Epstein-Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant TransformationHai Hu, Man-Li Luo, Christine Desmedt, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 26, 2003
WNT7a induces E-cadherin in lung cancer cellsTatsuo Ohira, Robert M Gemmill, Kevin Ferguson, et al.
Pageof 14